Literature DB >> 22682831

Re: First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.

Jerome P Richie.   

Abstract

Year:  2012        PMID： 22682831     DOI： 10.1016/j.juro.2012.03.060

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  1 in total

1.  Refractory lymphoma treated with chimeric antigen receptor T cells combined with programmed cell death-1 inhibitor: A case report.

Authors:  Cang-Jian Zhang; Jun-Yu Zhang; Lin-Jie Li; Neng-Wen Xu
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.